0001209191-15-032711.txt : 20150406
0001209191-15-032711.hdr.sgml : 20150406
20150406172313
ACCESSION NUMBER: 0001209191-15-032711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150402
FILED AS OF DATE: 20150406
DATE AS OF CHANGE: 20150406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 Broadway
STREET 2: 14TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-225-4348
MAIL ADDRESS:
STREET 1: 1 Broadway
STREET 2: 14TH FLOOR
CITY: Cambridge
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalowski Lee
CENTRAL INDEX KEY: 0001618273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 15754350
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-02
0
0001404281
Tokai Pharmaceuticals Inc
TKAI
0001618273
Kalowski Lee
C/O TOKAI PHARMACEUTICALS, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2015-04-02
4
S
0
2258
11.45
D
52346
D
Shares were sold to satisfy certain tax obligations of the Reporting Person triggered by the vesting of certain restricted stock units. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 per share to $11.66 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents 4,567 shares of common stock held by the Reporting Person and 47,779 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
/s/ Cindy Driscoll, Attorney-in-Fact
2015-04-06